Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin
Jazyk angličtina Země Itálie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
26416404
DOI
10.1007/s10238-015-0390-1
PII: 10.1007/s10238-015-0390-1
Knihovny.cz E-zdroje
- Klíčová slova
- Albumin, Antioxidant enzymes, Cytokines, HDL cholesterol, Oxidative stress, Sepsis,
- MeSH
- cytokiny krev MeSH
- HDL-cholesterol krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- oxidační stres MeSH
- prospektivní studie MeSH
- senioři MeSH
- sepse imunologie metabolismus MeSH
- sérový albumin metabolismus MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- cytokiny MeSH
- HDL-cholesterol MeSH
- sérový albumin MeSH
Markers of oxidative stress and antioxidant status in relation to inflammatory mediators in septic patients (SPs) during the course of sepsis and after recovery were analysed. Patients were 30 critically ill adults in severe sepsis/septic shock, 19 of which completed 3 samplings (S1: within 24 h after onset of sepsis, S7: 7 days after S1, R7: 7 days after clinical recovery). Comparing SPs with healthy controls (HCs), enhanced C-reactive protein, procalcitonin, bilirubin and CuZn-superoxide dismutase activity were found at S1 only. Oxidized low-density lipoprotein, conjugated dienes and nitrotyrosine were increased at S1, culminated at S7 and reverted nearly to HC levels at R7. Reduced catalase activity and serum amyloid were observed at S1 and endured until R7. Increase in IL-6, IL-10 and tumour necrosis factor alpha (TNF-α) with accompanying decrease in apolipoprotein A1, high-density lipoprotein (HDL) cholesterol, selenium, zinc, albumin, paraoxonase 1 and glutathione peroxidase 1 activity appeared at S1 and persisted until R7. TNF-α, IL-10 and markers of oxidative stress were in negative correlation with HDL cholesterol and albumin at R7. After clinical recovery, increased cytokines and decreased antioxidants were accompanied by lower albumin and HDL cholesterol levels. During this important and beneficial period of tissue repair, patients with prolonged persistence of this status are probably more vulnerable to secondary infections and should be dealt with as constituting a high-risk population.
Zobrazit více v PubMed
J Crit Care. 1995 Sep;10(3):122-35 PubMed
Biochem Pharmacol. 2000 Jan 15;59(2):187-94 PubMed
Clin Sci (Lond). 2009 Jan;116(2):87-98 PubMed
Crit Care Med. 2008 Jan;36(1):296-327 PubMed
Injury. 2011 Jul;42(7):617-29 PubMed
Arch Surg. 2001 Oct;136(10):1201-7 PubMed
Clin Chem. 1995 Jun;41(6 Pt 1):867-71 PubMed
Intensive Care Med. 1991;17(1):40-4 PubMed
Pharmacol Ther. 2013 Mar;137(3):341-51 PubMed
Crit Care Clin. 2006 Jul;22(3):489-501, ix PubMed
Metabolism. 1988 Sep;37(9):859-65 PubMed
Nature. 2014 Jun 5;510(7503):92-101 PubMed
J Biol Chem. 1998 Mar 13;273(11):6088-95 PubMed
Crit Care Med. 2003 Apr;31(4):1250-6 PubMed
Clin Chim Acta. 1998 Jun 22;274(2):177-88 PubMed
Arch Surg. 1999 Jan;134(1):36-42 PubMed
J Biol Chem. 1957 Nov;229(1):189-97 PubMed
Curr Opin Infect Dis. 2012 Jun;25(3):328-36 PubMed
Free Radic Biol Med. 2006 Feb 1;40(3):398-406 PubMed
Adv Exp Med Biol. 2010;660:89-97 PubMed
Clin Exp Med. 2010 Mar;10(1):21-5 PubMed
Am J Hum Genet. 1983 Nov;35(6):1126-38 PubMed
Biochem J. 1998 May 15;332 ( Pt 1):251-5 PubMed
Surg Infect (Larchmt). 2009 Aug;10(4):339-48 PubMed
J Crit Care. 2010 Jun;25(2):361.e7-361.e12 PubMed
Crit Care Med. 1995 Apr;23(4):646-51 PubMed
Circulation. 2009 Mar 3;119(8):1135-45 PubMed
Free Radic Biol Med. 1999 Apr;26(7-8):892-904 PubMed
Indian J Med Res. 2007 Feb;125(2):143-8 PubMed
Crit Care Med. 2003 May;31(5):1359-66 PubMed
Clin Biochem. 2009 Sep;42(13-14):1368-74 PubMed
Crit Care Med. 2000 Aug;28(8):2779-85 PubMed
Front Public Health. 2013 Nov 15;1:51 PubMed
Crit Care Med. 2001 Jul;29(7):1303-10 PubMed
Crit Care. 2007;11(2):R49 PubMed
J Antimicrob Chemother. 2011 Apr;66 Suppl 2:ii33-40 PubMed
N Engl J Med. 2003 Jan 9;348(2):138-50 PubMed
N Engl J Med. 1969 Nov 13;281(20):1081-6 PubMed
Biofactors. 2008;33(2):107-19 PubMed
Mediators Inflamm. 2008;2008:168652 PubMed
Clin Chem. 1997 Apr;43(4):562-8 PubMed
Biosci Rep. 2011 Feb;31(1):63-76 PubMed
J Crit Care. 2008 Dec;23 (4):537-41 PubMed
Saudi J Gastroenterol. 2010 Apr-Jun;16(2):79-83 PubMed
Arch Intern Med. 2007 Aug 13-27;167(15):1655-63 PubMed
Pediatr Clin North Am. 2008 Jun;55(3):647-68, xi PubMed
Crit Care Med. 2001 Aug;29(8):1563-8 PubMed
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1242-7 PubMed
Clin Biochem. 1996 Apr;29(2):139-44 PubMed
Am Rev Respir Dis. 1992 Oct;146(4):985-9 PubMed
Biochim Biophys Acta. 2013 Dec;1830(12):5405-17 PubMed
J Clin Pathol. 2001 Mar;54(3):176-86 PubMed
Eur J Clin Invest. 2007 Jul;37(7):573-9 PubMed
Atherosclerosis. 2006 Jun;186(2):396-401 PubMed
JAMA. 2001 Oct 10;286(14):1754-8 PubMed
Crit Care Med. 1998 Sep;26(9):1536-44 PubMed
Crit Care Med. 1999 Jul;27(7):1262-4 PubMed
J Infect Dis. 2000 Jan;181(1):176-80 PubMed
Free Radic Biol Med. 2004 Dec 15;37(12):1986-94 PubMed
N Engl J Med. 1999 Feb 11;340(6):448-54 PubMed
Aliment Pharmacol Ther. 2002 Dec;16 Suppl 5:6-11 PubMed
J Surg Res. 1994 Jul;57(1):197-204 PubMed
Clin Chest Med. 2008 Dec;29(4):617-25, viii PubMed
Crit Care. 2010;14(1):R15 PubMed
Atherosclerosis. 2011 Jan;214(1):20-36 PubMed